UTHR Financial Facts

Diluted (in shares): 51.91M
Basic (in shares): 46.09M
See Full Income Statement

Total liabilities and stockholders' equity: 1.74B
Cash and cash equivalents: 254.36M
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date 10/28/15 *Est. EPS Growth Rate -0.8% *Last Qtr.
Average EPS % Beat Rate +46.5% Revenue Growth Rate +7.6% *Last Qtr.
Average % Move 1-Wk after EPS -1.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/28/15 Q215 $2.55$2.31 +$0.24$347.2M$360.41M N/A Details
4/28/15 Q115 $2.55$2.14 +$0.41$327.6M$353.5M N/A Details
2/24/15 Q414 $3.21$2.03 +$1.18$346.4M$336.22M N/A Details
10/28/14 Q314 $3.91$1.97 +$1.94$330M$335.1M N/A Details
7/29/14 Q214 $2.57$1.75 +$0.82$322.8M$308.04M N/A Details
4/29/14 Q114 $1.77$1.65 +$0.12$289.4M$300.14M N/A Details
2/25/14 Q413 $2.88$1.51 +$1.37$289.02M$295.43M N/A Details
10/29/13 Q313 $2.98$1.59 +$1.39$302.2M$279.02M Details